FMR LLC 13D and 13G filings for ALX Oncology Holdings Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-06 11:33 am Sale | 2024-11-29 | 13G | ALX Oncology Holdings Inc. ALXO | FMR LLC | 1,798,875 3.400% | -4,066,231 (-69.33%) | Filing |
| 2024-11-12 09:50 am Sale | 2024-11-08 | 13G | ALX Oncology Holdings Inc. ALXO | FMR LLC | 5,865,106 11.135% | -1,607,715 (-21.51%) | Filing |
| 2024-02-09 08:35 am Purchase | 2024-02-08 | 13G | ALX Oncology Holdings Inc. ALXO | FMR LLC | 7,472,821 14.999% | 1,359,393 (+22.24%) | Filing |
| 2023-02-09 08:23 am Purchase | 2023-02-09 | 13G | ALX Oncology Holdings Inc. ALXO | FMR LLC | 6,113,428 15.000% | 1,832,912 (+42.82%) | Filing |
| 2022-08-10 08:10 am Purchase | 2022-08-09 | 13G | ALX Oncology Holdings Inc. ALXO | FMR LLC | 4,280,516 10.522% | 1,687,577 (+65.08%) | Filing |
| 2022-02-09 09:09 am Purchase | 2022-02-08 | 13G | ALX Oncology Holdings Inc. ALXO | FMR LLC | 2,592,939 6.402% | 2,592,939 (New Position) | Filing |